-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Return On Equity history and change rate from 2019 to Q3 2025.
- Nurix Therapeutics, Inc. Return On Equity for the quarter ending 31 Aug 2025 was -53.6 %, a 15.5% increase year-over-year.
- Nurix Therapeutics, Inc. annual Return On Equity for 2024 was -53.7 %, a 9.79% increase from 2023.
- Nurix Therapeutics, Inc. annual Return On Equity for 2023 was -59.5 %, a 0.47% decline from 2022.
- Nurix Therapeutics, Inc. annual Return On Equity for 2022 was -59.2 %, a 75% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)